COLAIANNI, GRAZIANA
 Distribuzione geografica
Continente #
NA - Nord America 5.551
EU - Europa 1.812
AS - Asia 843
SA - Sud America 25
OC - Oceania 7
Continente sconosciuto - Info sul continente non disponibili 3
Totale 8.241
Nazione #
US - Stati Uniti d'America 5.541
IT - Italia 736
CN - Cina 468
SE - Svezia 420
SG - Singapore 262
DE - Germania 124
UA - Ucraina 107
RU - Federazione Russa 96
FI - Finlandia 86
GB - Regno Unito 83
FR - Francia 62
IN - India 32
BE - Belgio 29
VN - Vietnam 25
IE - Irlanda 18
BR - Brasile 13
IR - Iran 11
NL - Olanda 11
CA - Canada 8
KR - Corea 8
AE - Emirati Arabi Uniti 7
CZ - Repubblica Ceca 7
HK - Hong Kong 7
AU - Australia 6
PK - Pakistan 5
AR - Argentina 4
AT - Austria 4
DK - Danimarca 4
ES - Italia 4
ID - Indonesia 4
LT - Lituania 4
EU - Europa 3
GR - Grecia 3
IQ - Iraq 3
MY - Malesia 3
NO - Norvegia 3
PE - Perù 3
BY - Bielorussia 2
EC - Ecuador 2
LV - Lettonia 2
BG - Bulgaria 1
CL - Cile 1
CO - Colombia 1
EE - Estonia 1
HR - Croazia 1
HU - Ungheria 1
JO - Giordania 1
JP - Giappone 1
KZ - Kazakistan 1
LI - Liechtenstein 1
LK - Sri Lanka 1
MX - Messico 1
NZ - Nuova Zelanda 1
PA - Panama 1
PH - Filippine 1
PL - Polonia 1
SA - Arabia Saudita 1
SK - Slovacchia (Repubblica Slovacca) 1
TH - Thailandia 1
TR - Turchia 1
VE - Venezuela 1
Totale 8.241
Città #
Fairfield 806
Woodbridge 557
Chandler 440
Houston 423
Ashburn 417
Bari 352
Nyköping 347
Cambridge 346
Seattle 341
Ann Arbor 300
Wilmington 279
Jacksonville 260
Singapore 182
Nanjing 104
Roxbury 104
Lawrence 95
Beijing 72
Des Moines 70
Grumo Appula 66
New York 65
Inglewood 57
Boardman 45
Brooklyn 43
Princeton 42
San Diego 36
Trani 33
Shenyang 30
Brussels 29
Jiaxing 27
Santa Clara 27
Dearborn 26
Milan 26
Dong Ket 25
Redwood City 24
London 23
Rome 23
Nanchang 22
Pune 22
Hebei 21
Changsha 19
Helsinki 18
Noicattaro 18
Dublin 17
Munich 17
Falls Church 16
Los Angeles 15
Paris 15
Tianjin 15
Zhengzhou 13
Guangzhou 11
Boydton 10
Ningbo 9
Orta Nova 9
Ardabil 8
Jinan 8
Toronto 8
Shanghai 7
Wuhan 7
Al Fujairah City 6
Belvedere Marittimo 6
Brno 6
Frankfurt am Main 6
Hefei 6
Mottola 6
Rho 6
Washington 6
Cerignola 5
Florence 5
Hong Kong 5
Redmond 5
San Francisco 5
San Mateo 5
Taranto 5
Augusta 4
Bandung 4
Charlotte 4
Hounslow 4
Kunming 4
Leawood 4
Norwalk 4
Serra D'aiello 4
Turin 4
Vienna 4
Auburn Hills 3
Baghdad 3
Buenos Aires 3
Fuzhou 3
Grottaglie 3
Hangzhou 3
Islamabad 3
Islington 3
Kuala Lumpur 3
Lima 3
Novara 3
Nuremberg 3
Nürnberg 3
Oslo 3
Raleigh 3
Randazzo 3
Recanati 3
Totale 6.621
Nome #
Irisin prevents microgravity-induced impairment of osteoblast differentiation in vitro during the space flight CRS-14 mission 216
Irisin serum levels are positively correlated with bone mineral status in a population of healthy children 147
Impairment of bone remodeling in LIGHT/TNFSF14-deficient mice 146
Functions of vasopressin and oxytocin in bone mass regulation 146
The myokine irisin increases cortical bone mass 139
High Sclerostin and Dickkopf-1 (DKK-1) serum levels in children and adolescents with type 1 diabetes mellitus 133
Effects of sweet cherry polyphenols on enhanced osteoclastogenesis associated with childhood obesity 129
Irisin prevents and restores bone loss and muscle atrophy in hind-limb suspended mice 122
Irisin and musculoskeletal health 121
null 120
Crosstalk Between Muscle and Bone Via the Muscle-Myokine Irisin 120
Oxytocin receptor nuclear translocation mediates upregulation of osteoblast specific genes 118
Irisin and Bone: From Preclinical Studies to the Evaluation of Its Circulating Levels in Different Populations of Human Subjects 116
Sclerostin stimulates angiogenesis in human endothelial cells 115
LIGHT/TNFSF14 as a new biomarker of bone disease in multiple myeloma patients experiencing therapeutic regimens 113
An update on the role of RANKL–RANK/osteoprotegerin and WNT-ß-catenin signaling pathways in pediatric diseases 111
Mechanisms involved in childhood obesity-related bone fragility 104
Deletion of the Transcription Factor PGC-1α in Mice Negatively Regulates Bone Mass 102
Role of Irisin on the bone-muscle functional unit 101
Light/TNFSF14 increases osteoclastogenesis and decreases osteoblastogenesis in multiple myeloma-bone disease. 101
Osteogenic differentiation of mesenchymal stem cells from dental bud: Role of integrins and cadherins 100
The effects of bone pâté on human osteoblasts cell cultures 99
Stemness genes expression in naïve vs. osteodifferentiated human dental-derived stem cells 99
High dickkopf-1 levels in sera and leukocytes from children with 21-hydroxylase deficiency on chronic glucocorticoid treatment 97
Irisin levels correlate with bone mineral density in soccer players 96
High irisin levels are associated with better glycemic control and bone health in children with Type 1 diabetes 96
null 96
Bone Marrow Oxytocin Mediates the Anabolic Action of Estrogen on the Skeleton 93
Monoclonal antibodies for treating osteoporosis 93
Human myeloma cell lines induce osteoblast down-regulation of CD99 which is involved in osteoblast formation and activity 90
FSH and TSH in the regulation of bone mass: the pituitary/immune/bone axis 88
In vitro osteoclastogenesis and bone resorption during spaceflight 86
Osteotropic Cancers: From Primary Tumor to Bone 86
Regulated production of the pituitary hormone oxytocin from murine and human osteoblasts 86
null 86
null 85
A Novel Mechanism of Signal Transduction: Oxytocin Receptors Activated by the Ligand Translocate in the Nucleus to Enhance Osteoblast Transcription 84
Irisin Serum Levels in Metabolic Syndrome Patients Treated with Three Different Diets: A Post-Hoc Analysis from a Randomized Controlled Clinical Trial 81
Microgravity during spaceflight directly affects in vitro osteoclastogenesis and bone resorption 79
Oxytocin is an Anabolic Bone Hormone 79
High expression of TRAIL by osteoblastic differentiated dental pulp stem cells affects myeloma cell viability 78
Mechanisms of Altered Bone Remodeling in Multiple Myeloma 76
Myokine Irisin and Its Effects Linking Bone and Muscle Function 76
The role of OPG/TRAIL complex in multiple myeloma: the OPG/TRAIL complex in an in vitro osteoclastogenesis model derived from human multiple myeloma-bone disease 75
A new titanium biofunctionalized interface based on poly(pyrrole-3-acetic acid) coating: proliferation of osteoblast-like cells and future perspectives 75
null 73
The Role of LIGHT in Multiple Myeloma-Bone Disease 73
Oxytocin decreases bone resorption upregulating nitric oxide synthase isoforms 72
THE ROLE OF LIGHT ON BONE REMODELING 71
null 71
In vitro bone resorption during Spaceflight 71
T cells support osteoclastogenesis in an in vitro model derived from human multiple myeloma bone disease: the role of the OPG/TRAIL interaction 71
LIGHT/TNFSF14 Promotes Osteolytic Bone Metastases in Non-small Cell Lung Cancer Patients 71
Oxytocin: an estrogen-controlled autocrine-paracrine modulator of osteoclastogenesis and bone resorption 70
Skeleton and glucose metabolism: a bone-pancreas loop 70
Lack of oxytocin retards osteoblast differentiation and bone formation 69
Human osteoclasts express oxytocin receptor 69
Synovial fluid fibroblasts and lymphocytes support the osteoclastogenesis in human psoriatic arthritis 69
null 69
The OPG/TRAIL complex in an in vitro osteoclastogenesis model derived from human multiple myeloma-bone disease 68
Dominant gender-non-specific direct regulation of osteoblasts and osteoclasts by the pituitary hormone oxytocin 67
T cells support the osteoclastogenesis in an in vitro model derived from human multiple myeloma bone disease 66
Increased osteoclast differentiation and bone resorption during space flight 64
T cells support the in vitro formation of osteoclasts in multiple myeloma-bone disease: the role of OPG/TRAIL interaction 64
Myokines and Osteokines in the Pathogenesis of Muscle and Bone Diseases 64
null 63
Irisin Prevents Disuse-Induced Osteocyte Apoptosis 63
Irisin Correlates Positively With BMD in a Cohort of Older Adult Patients and Downregulates the Senescent Marker p21 in Osteoblasts 62
null 60
LIGHT/TNFSF14 regulates estrogen deficiency-induced bone loss 60
Irisin for care and prevention of osteoporosis 60
A Novel Mechanism of Signal Transduction: Oxytocin Receptors Activated by the Ligand translocate in the Nucleus to enhance Osteoblast Specific Transcription 59
null 59
The effect of Irisin on bone cells in vivo and in vitro 59
Regulation of bone remodeling by vasopressin explains the bone loss in hyponatremia 58
Increased osteoclast activity in the presence of increased homocysteine concentrations 57
null 57
Irisin for care and prevention of osteoporosis 57
Irisin promotes growth, migration and matrix formation in human periodontal ligament cells 56
T cell-regulation of osteoclast formation and survival involving OPG/TRAIL interaction in an vitro model from human multiple myeloma 53
null 52
LIGHT as regulator of bone homeostasis during osteolytic bone metastasis formation in non-small cell lung cancer patients 52
Oxytocin Receptor Nuclear Translocation Could Be A Novel Mechanism Mediating Osteoblast Differentiation Induced By Oxytocin 51
null 49
Irisin, the novel myokine responsible for benefits of physical exercise on bone 48
Oxytocin receptor translocates into osteoblast nucleus and interacts with transcription factors possibly modulating osteoblast differentiation 47
Anatomy and physiology of skeletal tissue: The bone cells 47
In Reply to the Letter to the Editor: Involvement of Irisin in Age-Related Osteoporosis and Its Inhibitory Effect on the Senescent Marker p21 in Osteoblasts 46
Relevance of oxytocin on osteoclast properties: a comparison between culture of marrow derived osteoclasts from Oxytocin +/+ and -/- mice 45
Trascriptional activation of the oxytocin promoter by estroges requires an intanct MAP kinase pathway in osteoclasts and osteoblests: a novel non classical nuclear mechanism 45
Osteoclast gene expression and resorption during spaceflight 44
Irisin and Secondary Osteoporosis in Humans 43
Microgravity directly affects "Bone Resorbing" cells 42
Osteoclast oxytocin promoter: a novel non classical nuclear mechanism 41
The myokine Irisin recapitulates the effect of physical activity on bone and muscle tissues 41
null 41
Anatomy and physiology of adipose tissue 40
The multiple hormone responsive element on osteoclast oxytocin promoter responds to estrogen and thyroid hormone through different pathways: a novel non classical nuclear mechanism 39
Introduction to the special issue of cancer and bone-related disorder 38
Formazione di osteoclasti in un modello in vitro derivato da pazienti affetti da mieloma multiplo: interazione OPG/TRAIL 37
Totale 7.852
Categoria #
all - tutte 38.035
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 38.035


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020914 0 0 0 0 0 0 185 182 201 139 150 57
2020/20211.761 115 202 89 74 216 108 159 233 194 178 107 86
2021/2022946 71 83 10 29 45 82 28 36 96 68 160 238
2022/20231.344 177 165 96 87 132 188 33 155 228 14 28 41
2023/2024656 57 96 32 57 82 145 35 23 21 33 15 60
2024/2025803 147 30 174 88 62 296 6 0 0 0 0 0
Totale 8.676